Home
>
National Drug Code (NDC)
>
Transmucosal Fentanyl Citrate
Transmucosal Fentanyl Citrate - 52959-549-30 - (fentanyl citrate)
Drug Information of Transmucosal Fentanyl Citrate
| Product NDC: | 52959-549 |
| Proprietary Name: | Transmucosal Fentanyl Citrate |
| Non Proprietary Name: | fentanyl citrate |
| Active Ingredient(s): | 400 ug/1 & nbsp; fentanyl citrate |
| Administration Route(s): | ORAL; TRANSMUCOSAL |
| Dosage Form(s): | LOZENGE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Transmucosal Fentanyl Citrate
| Product NDC: | 52959-549 |
| Labeler Name: | H.J. Harkins Company, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020747 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060906 |
Package Information of Transmucosal Fentanyl Citrate
| Package NDC: | 52959-549-30 |
| Package Description: | 30 BLISTER PACK in 1 CARTON (52959-549-30) > 1 LOZENGE in 1 BLISTER PACK (52959-549-01) |
NDC Information of Transmucosal Fentanyl Citrate
| NDC Code | 52959-549-30 |
| Proprietary Name | Transmucosal Fentanyl Citrate |
| Package Description | 30 BLISTER PACK in 1 CARTON (52959-549-30) > 1 LOZENGE in 1 BLISTER PACK (52959-549-01) |
| Product NDC | 52959-549 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fentanyl citrate |
| Dosage Form Name | LOZENGE |
| Route Name | ORAL; TRANSMUCOSAL |
| Start Marketing Date | 20060906 |
| Marketing Category Name | NDA |
| Labeler Name | H.J. Harkins Company, Inc. |
| Substance Name | FENTANYL CITRATE |
| Strength Number | 400 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
